Article Details

Analyst Citigroup Price Target And Rating For Eiger BioPharmaceuticals Inc. (EIGR)

Retrieved on: 2022-06-12 01:03:52

Tags for this article:

Click the tags to see associated articles and topics

Analyst Citigroup Price Target And Rating For Eiger BioPharmaceuticals Inc. (EIGR). View article details on hiswai:

Excerpt

Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) concluded the trading at $5.64 on Friday, June 10, with a fall of -2.93% from its closing price on ...

Article found on: stocksregister.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up